Fiore Michael Henry 4

What Happened Michael H. Fiore, EVP and Chief Commercial Officer of HealthEquity, sold 2,470 shares in an open-market transaction on July 2, 2026, at $95.00 per share for gross proceeds of $234,650. The sale was reported on a Form 4 filed July 7, 2026. Sales are often routine (e.g., diversification or liquidity) and do not necessarily indicate negative views on the company.

Key Details

• Transaction date and price: July 2, 2026 — 2,470 shares sold at $95.00/share (proceeds $234,650).
• Transaction type/code: Sale (S), open market/private sale as reported.
• Shares owned after transaction: Not disclosed in the provided filing summary.
• Filing timeliness: Form 4 filed July 7, 2026 for a July 2 transaction — this appears to be outside the typical two-business-day filing window and may be late.
• Footnote: The sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 14, 2025.

Context

• Trades under 10b5-1 plans are pre-set trading arrangements and are generally considered less informative about an insider’s short-term views.
• For retail investors, isolated sales by an executive (especially when done under a trading plan) are common; multiple insider buys would typically be more noteworthy as signs of confidence.